Open Access

New potential antitumoral fluorescent tetracyclic thieno[3,2-b]pyridine derivatives: interaction with DNA and nanosized liposomes

  • Elisabete MS Castanheira1Email author,
  • Maria Solange D Carvalho1, 2,
  • Ana Rita O Rodrigues1,
  • Ricardo C Calhelha2 and
  • Maria-João RP Queiroz2
Nanoscale Research Letters20116:379

DOI: 10.1186/1556-276X-6-379

Received: 28 September 2010

Accepted: 12 May 2011

Published: 12 May 2011


Fluorescence properties of two new potential antitumoral tetracyclic thieno[3,2-b]pyridine derivatives were studied in solution and in liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from egg yolk; Egg-PC) and DODAB (dioctadecyldimethylammonium bromide). Compound 1, pyrido[2',3':3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-one, exhibits reasonably high fluorescence quantum yields in all solvents studied (0.20 ≤ ΦF ≤ 0.30), while for compound 2, 3-[(p-methoxyphenyl)ethynyl]pyrido[2',3':3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-one, the values are much lower (0.01 ≤ ΦF ≤ 0.05). The interaction of these compounds with salmon sperm DNA was studied using spectroscopic methods, allowing the determination of intrinsic binding constants, K i = (8.7 ± 0.9) × 103 M-1 for compound 1 and K i = (5.9 ± 0.6) × 103 M-1 for 2, and binding site sizes of n = 11 ± 3 and n = 7 ± 2 base pairs, respectively. Compound 2 is the most intercalative compound in salmon sperm DNA (35%), while for compound 1 only 11% of the molecules are intercalated. Studies of incorporation of both compounds in liposomes of DPPC, Egg-PC and DODAB revealed that compound 2 is mainly located in the hydrophobic region of the lipid bilayer, while compound 1 prefers a hydrated and fluid environment.


Liposomes are among technological delivery developments for chemotherapeutic drugs in the treatment of cancer. This technique can potentially overcome many common pharmacologic problems, such as those involving solubility, pharmacokinetics, in vivo stability and toxicity [13]. Liposomes are closed spherical vesicles consisting of a lipid bilayer that encapsulates an aqueous phase in which hydrophilic drugs can be stored, while water insoluble compounds can be incorporated in the hydrophobic region of the lipid bilayer [4].

In this work, two new potential antitumoral fluorescent planar tetracyclic thieno[3,2-b]pyridine derivatives 1 and 2 (Figure 1), previously synthesized by some of us [5], were encapsulated in liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from egg yolk) and DODAB (dioctadecyldimethylammonium bromide). DPPC and egg lecithin [egg yolk phosphatidylcholine (Egg-PC)] are neutral components of biological membranes, while cationic liposomes based on the synthetic lipid DODAB have been used as vehicles for DNA transfection and drug delivery [6]. These studies are important keeping in mind future drug delivery applications using these compounds as anticancer drugs.
Figure 1

Structure of the compounds 1 and 2.

Due to the antitumoral potential of the two compounds 1 and 2, related with their possible intercalation between the DNA base pairs, interactions with natural double-stranded salmon sperm DNA were studied. These interactions can be assessed using spectroscopic measurements, which are important tools for monitoring DNA-binding processes. The investigation based on DNA interactions has a key importance in order to understand the mechanisms of action of antitumor and antiviral drugs and to design new DNA-targeted drugs [7, 8]. Small molecules are stabilized on groove binding and intercalation with DNA through a series of associative interactions such as π-stacking, hydrogen bonding, attractive van der Waals and hydrophobic interactions [8]. The occurrence of intercalation seems to be an essential (but not sufficient) step for antitumoral activity [7]. Fluorescence quenching experiments using external quenchers are also very useful to distinguish between DNA binding modes [9] since intercalated molecules are less accessible to anionic quenchers due to electrostatic repulsion with negatively charged DNA [10].


Salmon sperm DNA from Invitrogen (Carlsbad, CA, USA) and compounds stock solutions were prepared in 10 mM Tris-HCl buffer (pH = 7.4), with 1 mM EDTA. The DNA concentration in number of bases was determined from the molar absorption coefficient, ε = 6600 M-1 cm-1 at 260 nm [11]. Fluorescence spectra of several solutions with different [DNA]/[compound] ratios and constant compound concentration (5 × 10-6 M) were recorded. The solutions were left several hours to stabilize.

Dipalmitoyl phosphatidylcholine (DPPC), egg yolk phosphatidylcholine (Egg-PC), from Sigma-Aldrich (St. Louis, Missouri, USA), and dioctadecyldimethylammonium bromide (DODAB), from Tokyo Kasei (Tokyo, Japan), were used as received. Liposomes were prepared by the ethanolic injection method, previously used for the preparation of Egg-PC and DPPC liposomes [1215] and DODAB vesicles [16, 17]. An ethanolic solution of a lipid/compound mixture was injected in an aqueous buffer solution under vigorous stirring, above the melting transition temperature of the lipid (approx. 41°C for DPPC [18] and 45°C for DODAB [19]). The final lipid concentration was 1 mM, with a compound/lipid molar ratio of 1:500. One millilitre solutions of liposome dispersions were placed in 3 mL disposable polystyrene cuvettes for dynamic light scattering (DLS) measurements in a Malvern ZetaSizer Nano ZS particle analyzer (Worcestershire, UK). Five independent measurements were performed for each sample. Malvern Dispersion Technology Software (DTS) (Worcestershire, UK) was used with multiple narrow mode (high resolution) data processing, and mean size (nm) and error values were considered.

Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR spectrophotometer (Kyoto, Japan) and fluorescence measurements were obtained in a Fluorolog 3 spectrofluorimeter (HORIBA Scientific, Kyoto, Japan) equipped with Glan-Thompson polarizers. Fluorescence spectra were corrected for the instrumental response of the system. The fluorescence quantum yields were determined by the standard method [20, 21], using 9,10-diphenylanthracene in ethanol as reference, Φr = 0.95 [22]. The solutions were previously bubbled for 20 min with ultrapure nitrogen.

Results and discussion

The size and size distribution of the liposomes prepared was obtained by DLS. All the liposomes have a mean hydrodynamic radius lower than 150 nm and generally low polydispersity. For Egg-PC and DODAB liposomes, the size distributions are bimodals and broader than for DPPC liposomes, the Egg-PC being the more polydisperse (Figure 2). The ethanolic injection method was described to produce phospholipid small unilamellar vesicles (SV) [1215]. Accordingly, DPPC and Egg-PC liposomes obtained here are in this category, with a mean diameter of around 90 nm for DPPC and 50 nm for Egg-PC. DODAB liposomes exhibit a significantly larger mean diameter (around 270 nm) than the phospholipid ones. The size of DODAB vesicles strongly depends on the preparation method, sonication and ethanolic injection giving small DODAB vesicles [17, 23, 24], while injection using chloroform yielded large DODAB vesicles [16]. Besides, spontaneously prepared DODAB liposomes have a much larger size (hydrodynamic radius around 337 nm [25]), being considered giant unilamellar vesicles (GUV). The DODAB liposomes mean diameter obtained here (ca. 270 nm) compares well with the reported value of 249 nm for DODAB SV [16]. In all samples, no experimental evidence of the presence of open bilayer fragments (diameter lower than 10 nm [17]) was obtained (Figure 2).
Figure 2

Size distributions obtained by dynamic light scattering (DLS) for DPPC, Egg-PC and DODAB liposomes prepared by the ethanolic injection method.

The absorption and fluorescence properties of compounds 1 and 2 were studied in several solvents (Table 1). The normalized fluorescence spectra of compounds 1 and 2 are shown in Figures 3 and 4. The fluorescence emission maximum of both compounds displays a loss of vibrational structure in polar solvents together with a small red shift (Figures 3 and 4), indicating some charge transfer character of the excited state [26]. The red shifts are more significant for compound 2 (Table 1), which may be due to a higher capability of this compound to establish hydrogen bonds with protic solvents (especially with water), due to the presence of the OCH3 group. Compound 1 has significantly higher fluorescence quantum yields (between 20 and 30%) than compound 2F between 1 and 5%), showing that the functionalization of the pyridine ring with a triple bond linked to a p-methoxyphenyl group causes a significant enhance of the non-radiative deactivation pathways. The fluorescence quantum yields of compound 1 are also higher than the ones of a benzo[b]thiophene derivative of the same type, a benzothienopyridopyrimidone [27], in which the benzene ring linked to the thiophene is substituted in compound 1 by a pyridine ring. The intrinsic fluorescence of compounds 1 and 2 can be used to monitor interactions with DNA and compounds behaviour when encapsulated in liposomes.
Table 1

Maximum absorption (λabs) and emission (λem) wavelengths, molar absorption coefficients (ε) and fluorescence quantum yields of compounds 1 and 2 in several solvents


λabs (nm) (ε/104 M-1 cm-1)

λem (nm)










398 (0.84); 377 (1.24); 360 (1.27); 305 (0.95); 258 (3.93)

411 sh (0.33); 354 (2.19); 347 (2.37); 308 (1.25); 291 (1.12); 270 (1.40)

402; 426; 452 sh

417; 441




398 (0.76); 377 (1.18); 359 (1.20); 305 (1.17); 258 (3.60)

411 sh (0.66); 356 (5.36); 346 (5.40); 309 (3.23); 291 (2.98); 272 (3.33)

407; 428; 455 sh

425; 449




397 (0.58); 377 (0.91); 360 (0.93); 305 (0.97); 259 (2.70)

410 sh (0.55); 357 (4.37); 311 (2.28); 290 (2.29); 273 (2.78)

408; 429

427; 448




395 (0.68); 376 (1.06); 358 (1.06); 304 (1.09); 256 (3.32)

409 sh (0.66); 355 (5.76); 308 (3.41); 289 (3.20); 271 (3.67)

408; 428





397 (0.78); 377 (1.19); 360 (1.16); 305 (1.19)

411 sh (0.69); 356 (5.52); 311 (3.11); 290 (2.86)

411; 430





397 (0.77); 378 (1.17); 361 (1.14); 305 (1.17)

412 sh (0.61); 357 (4.70); 313 (2.52)

413; 432





396 (0.69); 375 (1.13); 358 (1.17); 304 (1.40); 256 (3.59)

408 sh (0.72); 355 (5.50); 311 (2.95); 272 (3.69)

412; 431





395 (0.67); 374 (1.08); 358 (1.10); 304 (1.34); 256 (3.43)

408 sh (0.62); 354 (5.00); 311 (2.80); 272 (3.41)

413; 433





394 (0.41); 374 (0.57); 361 (0.58); 303 (0.93); 256 (2.07)

420 sh (0.26); 358 (0.87); 314 (0.94); 278 (0.97)

413 sh; 433




aSolvent cut-offs: N,N-Dimethylformamide: 275 nm; Dimethylsulfoxide: 280 nm; sh: shoulder.
Figure 3

Normalized fluorescence spectra (λ exc = 360 nm) of compound 1 (4 × 10 -6 M) in several solvents; the inset shows the absorption spectrum of 1 in dichloromethane (1 × 10 -4 M) as an example.
Figure 4

Normalized fluorescence spectra (λ exc = 360 nm) of compound 2 (4 × 10 -6 M) in several solvents; the inset shows the absorption spectrum of 2 in dichloromethane (2 × 10 -5 M) as an example.

Both compounds 1 and 2 were tested for their interaction with natural salmon sperm DNA using spectroscopic methods. For compound 1, fluorescence intensity decreases with increasing DNA concentration, while the opposite happens for compound 2 (Figures 5 and 6). This behaviour, also previously observed for differently substituted tetracyclic lactams [28], may indicate a different type of interaction of both compounds with the DNA molecule. For the two compounds, full saturation (corresponding to spectral invariance with increasing DNA concentration) is attained at [DNA]/[compound] = 200, meaning that total binding is achieved at this ratio. The high [DNA]/[compound] ratio needed for total binding, together with the negligible changes observed in absorption spectra (not shown), point to a weak interaction of these molecules with the nucleic acid.
Figure 5

Fluorescence spectra of compound 1 (5 × 10 -6 M) in 0.01 M Tris-HCl buffer (pH = 7.2), with increasing DNA content.
Figure 6

Fluorescence spectra of compound 2 (5 × 10 -6 M) in 0.01 M Tris-HCl buffer (pH = 7.2), with increasing DNA content.

The intrinsic binding constants (K i) and binding site sizes (n) were determined (Table 2) through the McGhee and von Hippel modification of Scatchard plot (Equation 1) [29],
Table 2

Values of the intrinsic binding constants (K i) and binding site sizes (n) and fraction of compound molecules accessible to external quenchers (f a ) for interaction with salmon sperm DNA


K i(M-1)


f a


(8.7 ± 0.9) × 103

11 ± 3



(5.9 ± 0.6) × 103

7 ± 2

where K i is the intrinsic binding constant, n the binding site size, r the ratio c b/[DNA] and c b and c f the concentrations of bound and free compound, respectively, calculated by

being I F,0 the fluorescence intensity of the free compound and I F,b the fluorescence intensity of the bound compound at total binding. The binding constants (Table 2) are moderately low, with a large number of base pairs between consecutive intercalated compound molecules (n).

Anionic quenchers can be useful in distinguishing between DNA binding modes [9, 10]. Compounds that are bound at the DNA surface (groove binding or electrostatic binding) are more accessible and emission from these molecules can be quenched more efficiently. Fluorescence quenching measurements using iodide ion showed that the usual Stern-Volmer plots (plots of the fluorescence intensity ratio in the absence, I 0, and presence, I, of quencher vs. quencher concentration) are not linear and exhibit a downward curvature (Figure 7A). This indicates that some compound molecules are not accessible to the anionic quencher, being intercalated between DNA base pairs. The modified Stern-Volmer plot [30] (Equation 3) allows the determination of the fraction of compound molecules accessible to quencher,
Figure 7

Stern-Volmer plots for quenching with iodide ion of compounds 1 and 2 for [DNA]/[compound] = 200 (A) and corresponding modified Stern-Volmer plots (B).

where I 0 is the fluorescence intensity in the absence of quencher, ΔI = I 0 - I, K SV the Stern-Volmer constant, [Q] the quencher concentration and f a the fraction of molecules accessible to quencher.

The representations of the modified Stern-Volmer plot are reasonably linear (Figure 7B) and the f a values are in Table 2. Both compounds exhibit some intercalation in DNA, compound 2 being the more intercalative one, with a lower fraction (65%) of molecules accessible to anionic quencher. The higher hydrophobic character of compound 2, promoted by the functionalization of the pyridine with a triple bond linked to a p-methoxyphenyl group, may justify this behaviour. As both compounds 1 and 2 are neutral molecules (and electrostatic interaction with the negatively charged DNA molecule is not expected), the high f a values indicate that the main type of interaction with the nucleic acid must be the binding to DNA grooves [28].

Fluorescence experiments of both compounds encapsulated in liposomes of DPPC, DODAB and Egg-PC were carried out (Figure 8), in both gel (below T m) and liquid-crystalline (above T m) phases. The melting transition temperature of Egg-PC is very low [31] and this lipid is in the fluid liquid-crystalline phase at room temperature. Fluorescence spectra of compound 1 incorporated in liposomes (Figure 8, Table 3) are roughly similar to the one obtained in pure water, regarding the band shape and maximum emission wavelength. Compound 2 in liposomes presents emission spectra similar to those in polar solvents, significantly blue-shifted relative to water. In Egg-PC, a band enlargement is observed in the blue region, which can indicate two different locations of compound 2 in these liposomes, one deep in the hydrophobic region and another more close to the lipid polar heads.
Figure 8

Normalized fluorescence emission spectra of compounds 1 and 2 incorporated in liposomes of DPPC, Egg-PC and DODAB.

Table 3

Steady-state fluorescence anisotropy (r) values and maximum emission wavelengths (λem) of compounds 1 and 2 incorporated in liposomes


Compound 1

Compound 2


λ em /nm


λ em /nm


DPPC (25°C)





DPPC (55°C)





Egg-PC (25°C)





DODAB (25°C)





DODAB (55°C)





Glycerol (25°C)





Values in glycerol are also shown for comparison.

Fluorescence anisotropy (r) measurements (Table 3) can give relevant information about the location of the compounds in liposomes, as r increases with the rotational correlation time of the fluorescent molecule (and, thus, with the viscosity of the fluorophore environment) [26]. Anisotropy values in a viscous solvent (glycerol) were also determined, for comparison. Anisotropy results (Table 3) allow to conclude that compound 2 is mainly located in the inner region of the lipid bilayer, feeling the penetration of some water molecules. The transition from the rigid gel phase to the liquid-crystalline phase is clearly detected by a significant decrease in anisotropy at 55°C observed in DPPC and DODAB liposomes. Compound 1 exhibits a different behaviour and anisotropy is very low in all types of liposomes (and much lower than in glycerol, Table 3). Overall, the results indicate that compound 1 prefers a hydrated and fluid environment and the transition from the gel phase to the liquid-crystalline phase is not detected. To further clarify the location of compound 1, the solutions of liposomes with incorporated compound were passed through filters of 0.05 μm diameter. The fluorescence emission of the filtered solutions was negligible, indicating that compound 1 is mainly in the liposome aqueous interior or located at the interfaces, with a very hydrated environment. This behaviour is similar to the observed previously for a benzothienopyridopyrimidone in lipid vesicles [27]. The encapsulation assays performed here may be important for future drug delivery applications of these potential antitumoral compounds using liposomes as drug carriers.


The interaction with DNA of two new potential antitumoral fluorescent planar thieno[3,2-b]pyridine derivatives was studied using spectroscopic methods. Compound 2 was shown to be the most intercalative compound in salmon sperm DNA (35%). The binding to DNA grooves seems to be the main type of interaction with the nucleic acid. Studies of incorporation of both compounds in liposomes of DPPC, Egg-PC and DODAB revealed that compound 2 is mainly located in the hydrophobic region of the lipid bilayer, while compound 1 prefers a hydrated and fluid environment. Our data thus suggest that both potential antitumoral compounds may be transported in liposomes for drug delivery applications.



dynamic light scattering


dioctadecyldimethylammonium bromide


dipalmitoyl phosphatidylcholine


Dispersion Technology Software


egg yolk phosphatidylcholine


giant unilamellar vesicles


small unilamellar vesicles.



This work was funded by FCT-Portugal through CFUM, CQ-UM, Project PTDC/QUI/81238/2006 (cofinanced by program FEDER/COMPETE, ref. FCOMP-01-0124-FEDER-007467) and PhD grants of M.S.D. Carvalho (SFRH/BD/47052/2008) and R.C. Calhelha (SFRH/BD/29274/2006).

Authors’ Affiliations

Centre of Physics (CFUM), University of Minho
Centre of Chemistry (CQ-UM), University of Minho


  1. Andresen TL, Jensen SS, Jorgensen K: Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005, 44: 68. 10.1016/j.plipres.2004.12.001View Article
  2. Ochekpe NA, Olorunfemi PO, Ngwuluka NC: Nanotechnology and drug delivery. Part 1: Background and applications. Tropical J Pharm Res 2009, 8: 265.
  3. Ochekpe NA, Olorunfemi PO, Ngwuluka NC: Nanotechnology and drug delivery. Part 2: Nanostructures for Drug Delivery. Tropical J Pharm Res 2009, 8: 275.
  4. Malam Y, Loizidou M, Seifalian AM: Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 2009, 30: 592. 10.1016/ Article
  5. Calhelha RC, Queiroz M-JRP: Synthesis of new thieno[3,2- b ]pyridine derivatives by palladium-catalyzed couplings and intramolecular cyclizations. Tetrahedron Lett 2010, 51: 281. 10.1016/j.tetlet.2009.10.138View Article
  6. Pedroso de Lima MC, Simões S, Pires P, Faneca H, Düzgünes N: Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 2001, 47: 277. 10.1016/S0169-409X(01)00110-7View Article
  7. Lyne PD: Structure-based virtual screening: an overview. Drug Discovery Today 2002, 7: 1047. 10.1016/S1359-6446(02)02483-2View Article
  8. Mahadevan S, Palaniandavar M: Spectroscopic and voltammetric studies of copper(II) complexes of bis(pyrid-2-yl)-di/trithia ligands bound to calf thymus DNA. Inorg Chim Acta 1997, 254: 291. 10.1016/S0020-1693(96)05175-4View Article
  9. Kumar CV, Asuncion EH: DNA-binding studies and site-selective fluorescence sensitization of an anthryl probe. J Am Chem Soc 1993, 115: 8547. 10.1021/ja00072a004View Article
  10. Kumar CV, Punzalan EHA, Tan WB: Adenine-thymine base pair recognition by an anthryl probe from the DNA minor groove. Tetrahedron 2000, 56: 7027. 10.1016/S0040-4020(00)00526-3View Article
  11. Renault E, Fontaine-Aupart MP, Tfibel T, Gardes-Albert M, Bisagni E: Spectroscopic study of the interaction of pazelliptine with nucleic acids. J Photochem Photobiol B Biol 1997, 40: 218. 10.1016/S1011-1344(97)00059-6View Article
  12. Batzri S, Korn ED: Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973, 298: 1015. 10.1016/0005-2736(73)90408-2View Article
  13. Kremer JMH, Esker MWJvd, Pathmamanoharan C, Wiersema PH: Vesicles of variable diameter prepared by a modified injection method. Biochemistry 1977, 16: 3932. 10.1021/bi00636a033View Article
  14. Nordlund JR, Schmidt CF, Dicken SN, Thompson TE: Transbilayer distribution of phosphatidylethanolamine in large and small unilamellar vesicles. Biochemistry 1981, 20: 3237. 10.1021/bi00514a039View Article
  15. Cruz A, Casals C, Plasencia I, Marsh D, Pérez-Gil J: Depth profiles of pulmonary surfactant protein B in phosphatidylcholine bilayers, studied by fluorescence and electron spin resonance spectroscopy. Biochemistry 1998, 37: 9488. 10.1021/bi971558vView Article
  16. Tsuruta LR, Carmona-Ribeiro AM: Counterion effects on colloid stability of cationic vesicles and bilayer-covered polystyrene microspheres. J Phys Chem 1996, 100: 7130. 10.1021/jp952535yView Article
  17. Pacheco LF, Carmona Ribeiro AM: Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. J Coll Interface Sci 2003, 258: 146. 10.1016/S0021-9797(02)00103-0View Article
  18. Lentz BR: Membrane fluidity as detected by diphenylhexatriene probes. Chem Phys Lipids 1989, 50: 171. 10.1016/0009-3084(89)90049-2View Article
  19. Feitosa E, Barreleiro PCA, Olofsson G: Phase transition in dioctadecyldimethylammonium bromide and chloride vesicles prepared by different methods. Chem Phys Lipids 2000, 105: 201. 10.1016/S0009-3084(00)00127-4View Article
  20. Demas JN, Crosby GA: Measurement of photoluminescence quantum yields - Review. J Phys Chem 1971, 75: 991. 10.1021/j100678a001View Article
  21. Fery-Forgues S, Lavabre D: Are fluorescence quantum yields so tricky to measure? A demonstration using familiar stationery products. J Chem Educ 1999, 76: 1260. 10.1021/ed076p1260View Article
  22. Morris JV, Mahaney MA, Huber JR: Fluorescence quantum yield determinations - 9,10-Diphenylanthracene as a reference-standard in different solvents. J Phys Chem 1976, 80: 969. 10.1021/j100550a010View Article
  23. Feitosa E, Brown W: Fragment and vesicle structures in sonicated dispersions of dioctadecyldimethylammonium bromide. Langmuir 1997, 13: 4810. 10.1021/la962034jView Article
  24. Andersson M, Hammarström L, Edwards K: Effect of bilayer phase-transitions on vesicle structure and its influence on the kinetics of viologen reduction. J Phys Chem 1995, 99: 14531. 10.1021/j100039a047View Article
  25. Lopes A, Edwards K, Feitosa E: Extruded vesicles of dioctadecyldimethylammonium bromide and chloride investigated by light scattering and cryogenic transmission electron microscopy. J Coll Interface Sci 2008, 322: 582. 10.1016/j.jcis.2008.03.015View Article
  26. Valeur B: Molecular Fluorescence - Principles and Applications. Weinheim: Wiley-VCH; 2002.
  27. Castanheira EMS, Pinto AMR, Queiroz MJRP: Fluorescence of a benzothienopyridopyrimidone in solution and in lipid vesicles. J Fluorescence 2006, 16: 251. 10.1007/s10895-005-0050-zView Article
  28. Queiroz M-JRP, Castanheira EMS, Lopes TCT, Cruz YK, Kirsch G: Synthesis of fluorescent tetracyclic lactams by a "one pot" three steps palladium-catalyzed borylation, Suzuki coupling (BSC) and lactamization. DNA and polynucleotides binding studies. J Photochem Photobiol A Chem 2007, 190: 45. 10.1016/j.jphotochem.2007.03.011View Article
  29. McGhee JD, von Hippel PH: Theoretical aspects of DNA-protein interactions - Cooperative and non-cooperative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 1974, 86: 469. 10.1016/0022-2836(74)90031-XView Article
  30. Lehrer SS: Solute perturbation of protein fluorescence - quenching of tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 1971, 10: 3254. 10.1021/bi00793a015View Article
  31. Papahadjopoulos D, Miller N: Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim Biophys Acta 1967, 135: 624. 10.1016/0005-2736(67)90094-6View Article


© Castanheira et al; licensee Springer. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.